A drug in use clinically to help make vaccines more effective may be a powerful new tool for fighting antibiotic-resistant infections.
Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.
Antimicrobial resistance continues to increase, and antimicrobial stewardship programs are developing plans to report antimicrobial use in order to reduce and optimize the use of antibiotics.
Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.
If you chat with Bob Wheaton, executive director of Vanderbilt Environmental Health and Safety, for a few minutes, it quickly becomes clear he’s not from around here.